Reporter Imaging of Protein-Protein Interactions
Reporter Imaging of Protein-Protein Interactions
批准号:
7255417
负责人:
SANJIV S GAMBHIR
金额:
$32.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2008-06-30
关键词:
17-(Allylamino)-17-demethoxygeldanamycinAreaBiological AssayBiological ProcessBiologyBioluminescenceCancer BiologyCaringCell LineCell NucleusCell membraneCell physiologyCellsClinicClinical MedicineCommunicationComplexCultured CellsCytoplasmDepthDevelopmentDevelopmental BiologyDisciplineDopamineDrug DesignEnzymesEventFoundationsFundingFutureGeldanamycin AnalogueGenetic TranscriptionGenetic TranslationGoalsHeadHeartHeat shock proteinsHeat-Shock Proteins 90Herpesvirus 1HybridsImageImaging technologyImplantInvasiveLeadLifeLocationMalignant NeoplasmsMeasuresMediatingMetabolismMethodsModalityModelingMolecularMonitorMultimodal ImagingMusNormal tissue morphologyNuclear ProteinNuclear ProteinsOpticsP23Pathway interactionsPharmaceutical PreparationsPharmacologic SubstancePositron-Emission TomographyPre-Clinical ModelProteinsReporterReporter GenesResearch PersonnelSignal TransductionSirolimusSystemSystems BiologyTechnologyTestingTherapeuticThymidine KinaseTimeTissuesTrans-ActivatorsTransactivationTransgenic ModelTransgenic OrganismsTranslatingValidationWorkXenograft ModelYeastsanticancer researchbasecancer therapycell assemblyclinically relevantdrug testinggene therapyin vivoinhibitor/antagonistinteininter-alpha-inhibitormolecular imagingmouse modelnew technologynovel strategiesoptical imagingpreclinical studyprogramspromoterprotein p23protein protein interactionrapid techniquereceptorreconstitutionresponsesmall moleculetooltumortumor xenograftvectoryeast two hybrid system
中文摘要
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant):
Molecular imaging continues to evolve into a discipline in its own right with applications to many areas of biology and clinical medicine. The long-term goal of this first-time competitive renewal application is to develop technologies focused on reporter genes for use with PET, optical, and other emerging modalities for applications to gene therapy, cancer biology, developmental biology, as well as many other areas. The general hypothesis is that reporter gene technologies can be developed and utilized to study fundamental molecular/cellular events in living subjects. Excellent progress has been made in this regard over the last 4 year funding period. We have helped to push the field forward by developing and validating enzyme based (Herpes-simplex Virus Type 1 thymidine kinase (HSVI-tk)) and receptor based (Dopamine Type 2 receptor (D2R)) reporter gene assays. We have applied these reporter genes primarily in the area of imaging gene therapy. The specific aims of the current renewal are to take the developed approaches to the next level by providing tools "systems imaging" by imaging intracellular networks in living subjects. Protein-protein interactions are at the heart of many biological process including normal and diseased tissue. In Aim 1 we refine a recently developed strategy to image protein-protein interactions that occur in the cell nucleus through an inducible yeast two-hybrid (IY2H) strategy. In Aim 2 we refine an alternate approach referred to as an inducible split reporter (ISR) strategy which is capable of measuring protein-protein interactions in many locations within a cell. In Aim 3 we test the imaging strategies developed in Aims 1 and 2 using new approaches being used to target the interaction of heat shock protein 90 (Hsp90) with p23 using geldanamycin analogs in tumor therapy models in living mice. Finally, in Aim 4 we develop transgenic models to further test methods for imaging protein-protein interactions in deep tissues of living mice. In all aims, care is taken to develop generalizable approaches that should be applicable to other studies using multimodality reporter gene approaches. The significance of the proposed work is it will help to develop and validate new technologies focused on imaging intracellular communication networks. This should lead to many applications including methods to image the interaction of drugs designed to inhibit protein-protein interaction in living subjects. More rapid methods to validate and translate pre-clinical models for cancer therapeutics into the clinic will likely result.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
World Molecular Imaging Congress 2017: IMAGinING the Future: from Molecules to Medicine
-
批准号:9398016
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2017
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Nanoparticle-Based Triple Modality Imaging and Photothermal Therapy of Brain Tumors
-
批准号:9092358
-
项目类别:
-
资助金额:$35.95万
-
财政年份:2016
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Nanoparticle-Based Triple Modality Imaging and Photothermal Therapy of Brain Tumors
-
批准号:9766199
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Optimization of an activatable photoacoustic agent to image thyroid cancer
-
批准号:9223698
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2015
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Developmental Program
-
批准号:8961578
-
项目类别:
-
资助金额:$15.01万
-
财政年份:2015
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Optimization of an activatable photoacoustic agent to image thyroid cancer
-
批准号:9060321
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2015
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
-
批准号:9324940
-
项目类别:
-
资助金额:$204.91万
-
财政年份:2015
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Vevo LAZR Photoacoustic and Ultrasound Imaging System
-
批准号:8447766
-
项目类别:
-
资助金额:$52.19万
-
财政年份:2013
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Improved Prostate Cancer Detection Using Combined Ultrasound and Photoacoustic Im
-
批准号:8569337
-
项目类别:
-
资助金额:$17.07万
-
财政年份:2013
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Administrative Core
-
批准号:7983248
-
项目类别:
-
资助金额:$10.54万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
-
批准号:8540368
-
项目类别:
-
资助金额:$233.45万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Pilot Projects
-
批准号:7983262
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Integration of Nano-Molecular Imaging and Nanosensors
-
批准号:7983246
-
项目类别:
-
资助金额:$19.35万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Career Development
-
批准号:7990939
-
项目类别:
-
资助金额:$8.24万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Monitoring Response to Targeted Therapy in Non-Small Cell Lung Cancer Using 18F..
-
批准号:7990870
-
项目类别:
-
资助金额:$89.3万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Alliance Challenge Projects
-
批准号:7983260
-
项目类别:
-
资助金额:$9.46万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
-
批准号:8134460
-
项目类别:
-
资助金额:$260.52万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Organization and Administration
-
批准号:7990869
-
项目类别:
-
资助金额:$6.9万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
-
批准号:8322769
-
项目类别:
-
资助金额:$255.11万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
-
批准号:8726310
-
项目类别:
-
资助金额:$237.48万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: